StockDriftsStockDriftsTop 5 SymBiosis Capital Partners, LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| EVMN | Evommune, Inc. | 55.8% | 1.28M | $29.4M | +0.00%(+0) | $17.12(-24.30%) | 2026-03-31 | |
| IVA | Inventiva S.A. | 24.76% | 2.35M | $13.1M | -9.46%(-246.00K) | $5.22(-25.10%) | 2026-03-31 | |
| WVE | Wave Life Sciences Ltd. | 10.3% | 750.0K | $5.4M | new | $12.13(-48.37%) | 2026-03-31 | |
| RANI | Rani Therapeutics Holdings, Inc. | 5.11% | 3.67M | $2.7M | -41.78%(-2.63M) | $0.93(-16.65%) | 2026-03-31 | |
| CLNN | Clene Nanomedicine Inc. | 4.03% | 431.1K | $2.1M | -44.05%(-339.40K) | $5.95(+2.52%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | -47.27% | -85.34% |
| Top 20 Holdings Unweighted | -64.75% | -95.62% |
Sign up free to track SymBiosis Capital Partners, LLC, compare funds side by side, and get alerts the moment positions change.